HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- ‘Surging burden’ of anal cancer requires more investigation, education
-
- Adjuvant and systemic therapy ‘rapidly evolving’ for rare ovarian tumors R. Wendel Naumann, MD; Erin K. Crane, MD; Jubilee Brown, MD
- Society for Neuro-Oncology meeting shows diverse treatment options emerging for glioblastoma David L. Jennings II, MSN, RN, AGPCNP-BC; Ashley L. Sumrall, MD
- American Urological Association presents award to Loyola Medicine professor
- Cleveland Clinic urologist named to American Health Council board
- Cryoablation may be viable alternative to surgery for some early breast cancers
- Emicizumab prophylaxis reduces bleeds in hemophilia A
- Fox Chase Cancer Center appoints assistant professor
- Medical director appointed for Smilow Cancer Hospital Care Centers
-
- Ohio State Comprehensive Cancer Center names associate director for basic research
- PEGPH20 extends PFS in advanced pancreatic cancer
- St. Jude Children’s Research Hospital appoints chair of bone marrow transplantation
- University Hospitals, Case Western researchers win NIH awards
- University of Pennsylvania chief of orthopedic oncology receives award
- Reflections on the value of new cancer drugs: The role of the man in the mirror John Sweetenham, MD, FRCP, FACP
- Amgen seeks full approval of Blincyto for Philadelphia chromosome–negative ALL
- FDA grants accelerated approval to Opdivo for urothelial carcinoma
-
- FDA grants breakthrough therapy designation to AMT-060 for severe hemophilia B
- FDA grants orphan drug designation to TG-1101, TGR-1202 combination for DLBCL
- FDA grants priority review to Keytruda for two urothelial cancer indications
- FDA grants priority review to Tecentriq for bladder cancer
- Physician, heal thyself, but be aware of the antitrust laws
- Chemoimmunotherapy combination remains standard of care in frontline treatment of advanced CLL
- Early palliative care improves satisfaction with care among caregivers
- End-of-life discussions held at ‘astounding’ infrequency
-
- Genital HPV prevalence remains high in men despite availability of vaccine
- Internet search engines can identify those at risk for lung cancer
- Left-sided tumor location reduces colon cancer mortality risk
- Melanoma deaths expected to fall dramatically by 2050
- Men diagnosed with prostate cancer often seek second opinions
- Overall US cancer deaths falling, but vary greatly by county
- Researchers identify previously unknown cause of SCID
- Restriction of indoor tanning among minors would reduce melanoma rates, treatment costs
-
- Systemic therapy used frequently in elderly patients with head, neck cancer
- Topotecan-based regimen improves ocular salvage, vision preservation in advanced retinoblastoma
- Vaginal ring, intravaginal testosterone cream appear safe, improve sexual dysfunction in postmenopausal women
- Benefits of immunotherapy for advanced kidney cancer may persist after therapy cessation
- Breath test shows promise for noninvasive diagnosis of esophageal, stomach cancer
- Liquid biopsies identify potential new treatment targets for advanced prostate cancer
- Pembrolizumab active against advanced mucosal melanoma
- Pembrolizumab improves OS in patients with advanced urothelial cancer
-
- Should planned surgery be considered for large, localized anal cancers?